Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.30ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
B.1.545ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
B.1.1.482ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
B.1.235ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BN.1.5ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BA.2.75.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BQ.1.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BA.4.1.8ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
FL.31.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
FF.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
AH.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-3617.02South Korea
B.55ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-3617.02South Korea
EG.2.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-3617.02South Korea
GS.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-3617.02South Korea
JN.1.48.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.1.180ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.243ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.1.291ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
BG.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
FL.2.5ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
BQ.1.1.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
JN.1.1.9ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.293ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
AY.39 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
AY.26 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
AY.3 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.545ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.1.482ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.403ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
B.1.1.412ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3577.4Germany
N.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-3577.39South Korea
FY.4.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-3573.1Japan
BQ.1.1.57SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3544.68China
BA.1.1.13ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-3534.45South Korea
BA.1.16ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-3534.45South Korea
XFORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-3534.45South Korea
BA.1.1.5ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-3534.45South Korea
HK.24.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-3525.68Japan
FL.20ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
B.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
B.1.595.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
B.1.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
EG.6.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
HN.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
CR.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
JN.1.36.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
BA.2.62ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
GK.2.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
BA.2.31ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
BA.2.32ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used